Ivan Hyep
Chief Financial Officer · 8 filings · Latest: Aug 10, 2026
Bicara Therapeutics Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
BCAX | Hyep Ivan | — | Sep 8, 2026 | Proposed Sale | $22.64 | 12,500 | $283.0K | — | |
BCAX | Ivan Hyep | Chief Financial Officer | Aug 10, 2026 | Sale | $27.97 | 12,500 | $349.6K | 129,855 | |
BCAX | Ivan Hyep | Chief Financial Officer | Aug 10, 2026 | Option Exercise | $3.79 | 12,500 | $47.4K | 142,355 | |
BCAX | Hyep Ivan | — | Aug 10, 2026 | Proposed Sale | $27.83 | 12,500 | $347.9K | — | |
BCAX | Ivan Hyep | Chief Financial Officer | Jul 8, 2026 | Sale | $28.85 | 28,000 | $807.7K | 129,855 | |
BCAX | Ivan Hyep | Chief Financial Officer | Jul 8, 2026 | Option Exercise | $3.79 | 12,500 | $47.4K | 157,855 | |
BCAX | Hyep Ivan | — | Jul 8, 2026 | Proposed Sale | $30.25 | 28,000 | $847.0K | — | |
BCAX | Ivan Hyep | Chief Financial Officer | May 21, 2026 | Sale | $20.42 | 9,200 | $187.9K | 145,355 | |
BCAX | Ivan Hyep | Chief Financial Officer | May 21, 2026 | Option Exercise | $3.79 | 9,200 | $34.9K | 154,555 | |
BCAX | Hyep Ivan | — | May 21, 2026 | Proposed Sale | $20.42 | 9,200 | $187.9K | — | |
BCAX | Ivan Hyep | Chief Financial Officer | Apr 21, 2026 | Sale | $23.00 | 9,200 | $211.6K | 145,355 | |
BCAX | Ivan Hyep | Chief Financial Officer | Apr 21, 2026 | Option Exercise | $3.79 | 9,200 | $34.9K | 154,555 | |
BCAX | Hyep Ivan | — | Apr 21, 2026 | Proposed Sale | $23.18 | 9,200 | $213.2K | — | |
BCAX | Ivan Hyep | Chief Financial Officer | Mar 23, 2026 | Sale | $18.52 | 9,200 | $170.3K | 145,355 | |
BCAX | Ivan Hyep | Chief Financial Officer | Mar 23, 2026 | Option Exercise | $3.79 | 9,200 | $34.9K | 154,555 | |
BCAX | Hyep Ivan | — | Mar 23, 2026 | Proposed Sale | $18.60 | 9,200 | $171.1K | — | |
BCAX | Ivan Hyep | Chief Financial Officer | Mar 4, 2026 | Sale | $18.25 | 2,963 | $54.1K | 145,355 | |
BCAX | Ivan Hyep | Chief Financial Officer | Mar 4, 2026 | Option Exercise | $3.79 | 2,963 | $11.2K | 148,318 | |
BCAX | Ivan Hyep | Chief Financial Officer | Mar 3, 2026 | Sale | $18.22 | 13,555 | $246.9K | 145,355 | |
BCAX | Ivan Hyep | Chief Financial Officer | Mar 3, 2026 | Option Exercise | $3.79 | 13,555 | $51.4K | 158,910 |
Page 1 of 2
Next →